Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study
European Urology Oncology(2018)
Abstract
Fear of chemotherapy-associated surgical complications hinders its use for muscle-invasive bladder cancer, despite guideline recommendations. Our study reports nationwide use of neoadjuvant chemotherapy for bladder cancer and demonstrates that neoadjuvant chemotherapy does not increase the morbidity of radical cystectomy.
MoreTranslated text
Key words
Bladder cancer,Neoadjuvant chemotherapy,Radical cystectomy,Complication,Morbidity,Mortality
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined